Lesinurad: A novel drug for the treatment of hyperuricemia associated with Gout in combination with a Xanthine Oxidase Inhibitor

Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2018, Vol 8, Issue 1

Abstract

Lesinurad is a selective inhibitor of URAT 1(Uric acid absorption inhibitor) and doesn’t inhibit organic anion transporters (e.g. OAT1 & 3) which make it to be an effective uricosuric agent with minimal clinically significant drug interactions, unlike probenecid. Lesinurad has been approved by USFDA ((United States Food and Drug Administration) on December 22nd , 2015, for the patients with gout, who didn’t achieve normal blood uric acid levels with xanthine oxidase inhibitor alone.

Authors and Affiliations

Sangeeta Bhanwra, Kaza Ahluwalia

Keywords

Related Articles

Circumcaval ureters can present late in life: A report of two cases with review of literature

Circumcaval or retrocaval ureter is a rare congenital anomaly with ureter passing dorsal to inferior vena cava (IVC) and more appropriately termed as preureteral vena cava (PVC). Although, it is a congenital anomaly but...

Persistent Post-Cholecystectomy Syndrome Secondary to Cystic Duct Stump Calculus - A Case Report

Cholecystectomy is the preferred surgical treatment for cholelithiasis. However occasionally, patients continue to have symptoms even after cholecystectomy. This is now a well-defined clinical entity that is labelled as...

Spontaneous perforation of gut by ventriculoperitoneal shunt: A rare complication

Ventriculoperitoneal (VP) shunting is the most common and effective treatment for hydrocephalus. Although a relatively simple procedure, its associated complications are not uncommon. Perforation of VP shunt into the abd...

Crossed Cerebellar Diaschisis in Middle Cerebral Artery Infarction

Crossed cerebellar diaschisis (CCD) is a condition involving deactivation of cerebellar neurons that results from loss of connections to injured cerebral neural tissues distant from cerebellum. Positron emission tomograp...

Antimicrobial Stewardship: Our Only Saviour in the Era of Superbugs

An Antimicrobial Stewardship Programme at the helm, is meant to integrate Clinical Microbiology, clinical pharmacology, medical and surgical sciences. It is a key instrument in working to improve the use of microbiologic...

Download PDF file
  • EP ID EP310819
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

Sangeeta Bhanwra, Kaza Ahluwalia (2018). Lesinurad: A novel drug for the treatment of hyperuricemia associated with Gout in combination with a Xanthine Oxidase Inhibitor. JOURNAL OF MEDICAL COLLEGE CHANDIGARH, 8(1), 27-31. https://europub.co.uk/articles/-A-310819